Impact Factor
3.94
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.19
674 total citations
h5-index
36
h5 depth signal
Cited share
93.2%
123 of 132
Total citations
674
Citation footprint
Metric signal
4.97
External metric anchor
Self-citation
2.2%
15 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
195
Italy
128
United States
107
India
67
Brazil
40
Citing Fields of Research
Oncology
160
Cancer, Autophagy & Apoptosis
121
Immunology
96
Cancer Drugs
84
Molecular Pharmacology
70
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,687
Articles tracked across the journal lifetime
Indexed publication set
132
123 cited publications
Last 12 months
54
4.5 publications/month
Open access share
13.0%
7 OA publications in the last year
Leading citing country
China
195 citing publications
Leading citing field
Oncology
160 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v19n1, Jan. 2009-
v19n1, Jan. 2009-
Research Focus & Classification
Indexed Subjects
Immunology
Cancer, Autophagy & Apoptosis
Oncology
Diabetes
Genetics & Genomics
Cancer & Development
Broad Categories
Therapeutics
Cancer, Autophagy & Apoptosis
Immunology
Cellular Membrane Transporters & Receptors
Molecular & Cellular Toxicology
Hematology
Cancer Drugs
MeSH Descriptors
Drug Approval
Patents as Topic
Pharmaceutical Preparations
Therapeutics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/13543776.2026.2748593
Open DOI
A patenting perspective of IKZF2 molecular glue degraders (2020-present)
02
DOI 10.1080/13543776.2026.2748595
Open DOI
Positive allosteric modulators of AMPA receptors: advances and emerging trends
03
DOI 10.1080/13543776.2026.2735861
Open DOI
Progress with FAK inhibitors in the patent literature (2020-present)
1. Located at focal adhesions (FAs), FAK is a non-receptor protein tyrosine kinase. It integrates upstream stimuli from integrins, receptor tyrosine kinases (RTKs), G-protein-coupled receptors, and...
04
DOI 10.1080/13543776.2026.2733162
Open DOI
Aurora kinase inhibitors: an updated patent review (2021–present)
1. Cancer is the second leading cause of death. Take the United States as an example, it is estimated that in 2026 there will be 2.11 million new cancer cases and 620,000 cancer deaths [1]. By 2040...
05
DOI 10.1080/13543776.2026.2726449
Open DOI
Global patent landscape of synthetic drugs for melasma (2015–2025): innovation trends, mechanistic shifts, and translational challenges
1. Melasma is one of the most prevalent forms of facial hyperpigmentation worldwide, characterized by its chronic, acquired, and recurrent nature, and mainly affecting women of reproductive age. Th...
06
DOI 10.1080/13543776.2026.2725660
Open DOI
Overcoming the blood–brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020–present)
07
DOI 10.1080/13543776.2026.2722028
Open DOI
Selective PARP1 inhibitors (2021–2025): patent landscape, structural evolution, and future therapeutic opportunities
1. DNA is continuously exposed to endogenous and exogenous insults, including reactive metabolic byproducts, replication stress, radiation, and chemical agents, all of which can induce structural d...
08
DOI 10.1080/13543776.2026.2713551
Open DOI
An updated patent review of STAT6 inhibitors and modulators (2020 – present)
1. The signal transducer and activator of transcription (STAT) protein family comprises cytoplasmic transcription factors that play a pivotal role as mediators between the extracellular signals and...
09
DOI 10.1080/13543776.2026.2710227
Open DOI
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage
1. Herpes simplex virus (HSV) infections are highly prevalent worldwide, affecting billions of individuals. According to the World Health Organization, approximately 3.7–3.8 billion people under 50...
10
DOI 10.1080/13543776.2026.2713553
Open DOI
T-type calcium channel blockers: a review of recent advances (2018–2025)
1. Voltage-gated calcium channels permit the depolarization-induced entry of calcium ions into electrically excitable cells such as neurons and cardiac myocytes [1]. Among the family of voltage-gat...
Bibliographical & Catalog Notes
Also issued online.